11.6 mg/g, gel
Diclofenac diethylammonium
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Voltaren Emulgel is a white gel for topical application to the skin. The active substance of the medicine, diclofenac, belongs to a group of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). Due to its water-alcohol base, Voltaren Emulgel also has a soothing and cooling effect.
The medicine has analgesic, anti-inflammatory, and anti-swelling effects.
It is used for local treatment of:
Adults (over 18 years old):
If any of the above statements apply to the patient, they should not use Voltaren Emulgel.
Before starting to use Voltaren Emulgel, discuss it with a doctor or pharmacist.
In case of any questions, consult a doctor or pharmacist before using Voltaren Emulgel.
Since there is insufficient data on the efficacy and safety of using Voltaren Emulgel in children and adolescents under 14 years old, the medicine should not be used in this age group.
In adolescents over 14 years old, if the medicine needs to be used for more than 7 days to treat pain or if symptoms worsen, the patient should consult a doctor.
Inform a doctor or pharmacist about all prescription or over-the-counter medicines the patient is currently taking or has recently taken, as well as any medicines they plan to take.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before using this medicine.
Voltaren Emulgel should not be used during the last three months of pregnancy, as it may harm the unborn child or cause difficulties during delivery.
During the first six months of pregnancy, Voltaren Emulgel should only be used on the advice of a doctor, with the lowest possible dose and for the shortest possible duration.
During breastfeeding, Voltaren Emulgel may be used only on the advice of a doctor, as diclofenac passes into breast milk in small amounts. In such cases, the medicine should not be applied to the breasts of nursing women or to large areas of skin or for extended periods.
Using the medicine does not affect driving or operating machines.
The medicine contains propylene glycol and benzyl benzoate, which may cause skin irritation.
Voltaren Emulgel contains fragrances with benzyl alcohol, citral, citronellol, coumarin, d-limonene, eugenol, farnesol, geraniol, linalool, which may cause allergic reactions.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist. In case of doubt, consult a doctor or pharmacist.
Voltaren Emulgel should be applied topically to the skin three or four times a day, gently rubbing it in.
To open the tube, before the first use, twist the cap, place it upside down on the seal, and twist it, which will allow the seal to be removed from the tube.
Gently squeeze a small amount of gel from the tube and apply it to the painful or swollen area of skin, slowly rubbing it in. The amount of gel should be adjusted to the size of the affected area:
a amount corresponding to the size of a cherry or a walnut is sufficient.
While rubbing in the gel, a slight cooling effect may be felt.
Voltaren Emulgel is for external use only.
After applying the medicine, the patient should:
Do notuse the medicine for longer than:
Use the smallest recommended dose for the shortest possible time.
If pain and swelling do not improve within 7 days or worsen, consult a doctor.
In case of using an excessive amount of Voltaren Emulgel, the excess should be removed with a tissue. If the medicine is swallowed, consult a doctor immediately.
If a dose is missed, apply the medicine as soon as possible, and then continue with the recommended dosing schedule. Do not use a double dose to make up for the missed dose.
In case of any questions about using Voltaren Emulgel, consult a doctor or pharmacist.
Like all medicines, Voltaren Emulgel can cause side effects, although not everybody gets them.
Other side effects that may occur when using Voltaren Emulgel are usually mild and temporary. If any of the following symptoms occur, inform a doctor or pharmacist as soon as possible.
If any side effects occur, including any possible side effects not listed in the leaflet, inform a doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 30°C.
After use, store the tube in an upright position.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask a pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the medicine is diclofenac diethylammonium. 1 gram of gel contains 11.6 mg of diclofenac diethylammonium (as diclofenac diethylammonium salt).
1 gram of the medicine contains 50 mg of propylene glycol and 1 mg of benzyl benzoate.
The other ingredients of the medicine are: diethylamine, cetomacrogol, carbomer 974P, isopropyl alcohol, liquid paraffin, fragrance (Perfume cream 45 – contains benzyl benzoate), purified water.
The medicine is available in tubes (aluminum or laminated) of 50 g and 100 g, in a cardboard box.
For more detailed information, consult the marketing authorization holder or parallel importer.
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
Barthstrasse 4
80339 Munich
Germany
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
Barthstrasse 4
80339 Munich
Germany
Purna Pharmaceuticals NV
Rijksweg 17
B-2870 Puurs
Belgium
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Germany, the country of export:520.00.03
Parallel import authorization number:736/12
Date of leaflet approval: 18.11.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.